AEMULUS HOLDINGS BERHAD. (“AEMULUS” OR “COMPANY”) NON-RELATED PARTY TRANSACTIONAemulus Holdings • April 11th, 2022
CAPITAL INJECTION AGREEMENT BETWEEN AEMULUS CORPORATION SDN. BHD., A WHOLLY-OWNED SUBSIDIARY OF THE COMPANY AND TANGREN MICROTELLIGENCE TECHNOLOGY (JIASHAN) CO., LTD. AND TANGMING SHENGSHI TECHNOLOGY (JIASHAN) CO., LTD.
SUPPLEMENTAL AGREEMENT TO THE JOINT VENTURE AGREEMENT BETWEEN AEMULUS CORPORATION SDN. BHD., A WHOLLY-OWNED SUBSIDIARY OF THE COMPANY AND TANGREN MICROTELLIGENCE TECHNOLOGY CO., LTD.Aemulus Holdings • December 3rd, 2020
The Board of Directors of the Company wishes to inform that Aemulus Corporation Sdn. Bhd. (“ACSB”), a wholly-owned subsidiary of the Company had on 3 December 2020, entered into a supplemental agreement with Tangren Microtelligence Technology Co., Ltd. (唐人制造(宁波)有限公司) (“Tangren Microtelligence”) and Tangren Microtelligence Technology (Jiashan) Co., Ltd. (唐人制造(嘉善)有限公司) (“Tangren (Jiashan)”), a wholly owned subsidiary of Tangren Microtelligence for the purpose of matters related to the change of the counterparty of the Joint Venture Agreement (“JVA”) upon the terms and condition of the Supplemental Agreement (the “Supplemental Agreement”).
